ESMO Immuno-Oncology Congress 2019 December 11–14, 2019 / Geneva / Switzerland AMAL Team attending
About Aurelie Kowalski
This author has yet to write their bio.Meanwhile lets just say that we are proud Aurelie Kowalski contributed a whooping 4 entries.
Entries by Aurelie Kowalski
BIO-Europe 2019 November 11–13, 2019 / Hamburg / Germany Laurence de Schoulepnikoff attending
Natera, Inc., a global leader in cell-free DNA testing, will partner with AMAL Therapeutics on a clinical trial focused on stage IV colorectal cancer. This study adds to the growing number of pharmaceutical trials using Natera’s SignateraTM molecular residual disease (MRD) assay as a biomarker to assess treatment response. View PDF
Swiss Biotech Day 2019 May 7, 2019 / Basel / Switzerland Laurence de Schoulepnikoff attending